gene	chromosome	start	end	applicableMutationType	source	entryDate	sourceEvent	sourceUrls	nctId	title	acronym	genderCriterium	countriesAndCities	hospitalsPerCity	treatment	treatmentApproachesDrugClass	treatmentApproachesTherapy	applicableCancerType	applicableDoid	blacklistCancerTypes	efficacyDescription	evidenceYear	evidenceLevel	evidenceLevelDetails	direction	evidenceUrls
EGFR	7	55241707	55279321	INFRAME	CKB_TRIAL	1970-01-01	exon 21		NCT1	study1			Belgium(Brussel)	Brussel(UZ Brussel)	Erlotinib			Pancreas	X			2024	B	GUIDELINE	RESISTANT	http
EGFR	7	55241707	55279321	INFRAME	CKB_EVIDENCE		exon 21								Erlotinib			Lung Adeno	X		efficacy evidence	2024	B	GUIDELINE	RESISTANT	http